A common symptom-based disorder which affects 5-15% of the adult population world-wide
For some, symptoms can be severe, frequent and significantly impact on quality of life
Commonly regarded as reflecting a dysfunction of the gut-brain axis, low grade inflammation and dysbiosis of the microbiota have been implicated of late
Management continues to be challenging with approaches which aim to alleviate individual symptoms (pain, constipation, diarrhoea) continuing to dominate in the absence of truly disease-modifying therapies.
Quigley, E.M.M. (2011, January 5). Irritable bowel syndrome (IBS) [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved May 9, 2021, from https://hstalks.com/bs/1913/.
Published on January 5, 2011
Prof. Eamonn M. M. Quigley, Consultant: Alimentary Health, Allergen, Commonwealth Laboratories, Rhythm, Salix, Synergy, Vibrant
Speaker’s Bureau: Procter and Gamble
Grant/Research Support (Principal Investigator): Rhythm, Therevance, Vibrant
Stock Shareholder (Self-managed): Alimentary Health